Serum tumor markers, such as CEA, SCCA, CYFRA 21-1, NSE, and ProGRP, are considered to be predictive or prognostic in NSCLC, and some of these markers have been shown to be correlated with EGFR mutations (33). The gene discussed is ENO2; the disease is non-small cell lung carcinoma.